Hoppa till innehållet

OMXSPI-0,44%

S&P 500+0,02%

FTSE 100-0,76%

DAX-0,52%

NIKKEI-0,11%
Enzymatica AB: BioStock: MDR certification was Enzymatica's highlight in Q1

Enzymatica has recently published its Q1 report, where the MDR certification for ColdZyme stands out as the key milestone during the quarter.
- The MDR certification was a labor-intensive and costly process, but now that ColdZyme has been certified as one of the first cold products in Europe, it opens up great commercial opportunities.

Read the full article at biostock.se (https://www.biostock.se/en/):

https://www.biostock.se/en/2024/04/mdr-certification-was-enzymaticas-highlight-in-q1/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Source:Cision
Tillbaka

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill du bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.

spara
1180kr
Prenumerera